Torrie Brittain Kosic Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 351 W Washington St, Arcola, IL 61910 Phone: 217-268-4961 |
Mrs. Valerie Sue Traub Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 351 W Washington St, Arcola, IL 61910 Phone: 217-268-4961 |
News Archive
Alnylam Pharmaceuticals, Inc. has announced new results from its ongoing Phase 2 open-label extension (OLE) studies with patisiran and revusiran, investigational RNAi therapeutics targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR amyloidosis).
Scientists from Duke University Medical Center have determined that genes acting as molecular "on/off" switches can define clinically relevant molecular subtypes of ovarian cancer, providing ideal potential targets for use in clinical prognostic and diagnostic testing.
A. Thomas McLellan, Ph.D. the top federal official on addiction treatment, chose Wiley newsletter Alcoholism & Drug Abuse Weekly for his first interview after being sworn in as deputy director of the White House Office of National Drug Control Policy. Published in the Aug. 31 issue, the interview reveals the bold directions McLellan plans to head in, including a new focus on probation and parole, in partnership with Gil Kerlikowske, ONDCP director.
Every Thursday, KHN's Jessica Marcy compiles this selection of interesting perspectives, from a variety of publications, on health care in America.
› Verified 8 days ago